This was the dosage regime for pediatric P3 aGVHD trial
"Subjects will be treated with intravenous (IV) remestemcel-L at a dose of 2 x 10e6 MSC/kg (actual body weight at screening) twice per week for each of 4 consecutive weeks."
So you yes 8 versus 2 doses, not sure of number of cells/kg rate though. I haven't been able to find the CTSN/NIH trial yet, maybe I'm using wrong search terms?
- Forums
- ASX - By Stock
- MSB
- VILI and MSCs
VILI and MSCs, page-13
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.11 |
Change
0.005(0.45%) |
Mkt cap ! $1.278B |
Open | High | Low | Value | Volume |
$1.13 | $1.16 | $1.10 | $5.169M | 4.621M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 111391 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.12 | 50770 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8 | 1.110 |
26 | 111264 | 1.105 |
15 | 157998 | 1.100 |
20 | 418874 | 1.095 |
13 | 100703 | 1.090 |
Price($) | Vol. | No. |
---|---|---|
1.115 | 51080 | 14 |
1.120 | 87551 | 10 |
1.125 | 166346 | 13 |
1.130 | 47710 | 4 |
1.135 | 76754 | 5 |
Last trade - 13.40pm 08/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |